Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, 27 mai 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), opérateur de marchés réglementés pour la négociation de plus de 12,000 titres américains et internationaux, a annoncé...
-
With over 100 million people forcibly displaced worldwide, the humanitarian system faces unprecedented challenges in funding essential services. In response, an innovative financial product—the...
-
PERTH, AUSTRALIA, May 23, 2025 (GLOBE NEWSWIRE) -- Globavend Holdings Limited (Nasdaq: GVH) (the “Company” or “Globavend”), an emerging e-commerce logistics provider, today announced that it...
-
NEW YORK, May 16, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading will resume in Damon Inc. (Nasdaq: DMN) at 9:00 a.m. Eastern Time on May 19, 2025. Trading...
-
SANTIAGO, Chile, May 14, 2025 (GLOBE NEWSWIRE) -- BANCO ITAÚ CHILE (SSE: ITAUCL) – – S&P Global Ratings (“S&P”) revised its outlook on Banco Itau Chile to “Positive” from “Stable”, based on...
-
SINGAPORE, May 13, 2025 (GLOBE NEWSWIRE) -- OMS Energy Technologies Inc. (“OMS” or the “Company”) (NASDAQ: OMSE), a growth-oriented manufacturer of surface wellhead systems and oil country tubular...
-
ARTEX Global Markets now accessible through SIX Swiss Exchange Infrastructure ARTEX Global Markets is pleased to announce enhanced connectivity with SIX Swiss Exchange, offering direct connectivity...
-
Euronext announces volumes for April 2025 Amsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 9 May 2025 – Euronext, the leading European capital market infrastructure, today...
-
ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal...
-
ROCKVILLE, MD, May 01, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...